Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2024, Vol. 29 ›› Issue (7): 826-830.doi: 10.12092/j.issn.1009-2501.2024.07.013

Previous Articles     Next Articles

Clinical research progress of esketamine application within the spinal canal

SUN Yufeng1, YANG Xiaolin1, DING Ying1, LV Yanrong1, WU Hongwei1, YANG Chun2   

  1. 1 Department of Anesthesiology, Rugao Hospital affiliated to Nantong University (Rugao People's Hospital), Rugao 226500, Jiangsu, China; 2 Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210020, Jiangsu, China
  • Received:2023-10-22 Revised:2023-12-15 Online:2024-07-26 Published:2024-06-24

Abstract:

Esketamine, which was recently introduced in China, is a type of intravenous general anesthetic that is widely used in clinical practice for general anesthesia and anti-depression therapy. Studies have found that esketamine can be safely used to intrathecally produce analgesic, sedative, and anti-depressive effects at subanesthetic doses. This review summarizes the mechanism of action, safety, adverse reactions, and various clinical applications of esketamine intrathecally, so as to provide relevant references for further research.

Key words: esketamine, spinal canal, analgesia, antidepressant

CLC Number: